Sanofi India Limited (BOM:500674)
India · Delayed Price · Currency is INR 4,010.25
-47.90 (-1.18%)
At close: Feb 12, 2026
Sanofi India Revenue
Sanofi India had revenue of 4.75B INR in the quarter ending September 30, 2025, a decrease of -9.27%. This brings the company's revenue in the last twelve months to 19.33B, down -31.53% year-over-year. In the year 2024, Sanofi India had annual revenue of 20.13B with 0.86% growth.
Revenue (ttm)
19.33B
Revenue Growth
-31.53%
P/S Ratio
4.78
Revenue / Employee
15.78M
Employees
1,225
Market Cap
92.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20.13B | 171.00M | 0.86% |
| Dec 31, 2023 | 19.96B | -7.74B | -27.94% |
| Dec 31, 2022 | 27.70B | -1.87B | -6.31% |
| Dec 31, 2021 | 29.57B | 547.00M | 1.88% |
| Dec 31, 2020 | 29.02B | -1.69B | -5.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jubilant Pharmova | 79.18B |
| Granules India | 50.92B |
| J. B. Chemicals & Pharmaceuticals | 41.93B |
| Caplin Point Laboratories | 20.92B |
| FDC Limited | 20.78B |
| AstraZeneca Pharma India | 20.06B |
| Viyash Scientific | 18.17B |
| Rubicon Research | 15.98B |
Sanofi India News
- 3 months ago - Sanofi India Ltd (BOM:500674) Q3 2026 Earnings Call Highlights: Strategic Shifts and Financial Gains - GuruFocus
- 3 months ago - Q3 2026 Sanofi India Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Sanofi India Q2 Results: Revenue falls 9.3% YoY to Rs 475.4 crore, net profit down 7.5% - Business Upturn
- 3 months ago - Sanofi India appoints Deepak Arora as new Managing Director, effective October 27, 2025 - Business Upturn
- 7 months ago - Sanofi India shares fall over 2% as Q1 revenue drops 12.4% YoY to Rs 406 crore, Ebitda down 18% - Business Upturn
- 7 months ago - Emcure and Sanofi India announce exclusive partnership to distribute oral anti-diabetic drugs in India - Business Upturn
- 9 months ago - Sanofi India shares jumpo over 2% following Q4 FY25 Results - Business Upturn
- 1 year ago - Sanofi India shares surge 6% on Q4 results; Rs 117 final dividend recommendation - Business Upturn